The Relevance of Factor VIII Inactivation Characteristics in the Treatment of Patients with Antibodies Directed against Factor VIII
- 1 June 1972
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 22 (6) , 735-742
- https://doi.org/10.1111/j.1365-2141.1972.tb05718.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Acquired Circulating Anticoagulants in Hemophilia ANew England Journal of Medicine, 1969
- Immunologic Characterization of 12 Factor VIII InhibitorsBlood, 1969
- Characterization and Properties of an Inhibitor of Factor VIII in the Plasma of Patients with Hemophilia A Following Repeated TransfusionsBlood, 1967
- The Immunologic Character of Acquired Inhibitors of Antihemophilic Globulin (Factor VIII) and the Kinetics of Their Interaction with Factor VIII*Journal of Clinical Investigation, 1967
- Antibody Nature of the Inhibitor to Antihaemophilic Globulin (Factor VIII)Nature, 1966
- An Antitihaemophilic Globulin (Factor VIII) Inhibitor: Purification, Characterization and Reaction KineticsBritish Journal of Haematology, 1963
- CIRCULATING ANTICOAGULANTSMedicine, 1961
- A Method for the Study of Antihaemophilic Globulin Inhibitors with Reference to Six CasesBritish Journal of Haematology, 1959